First-Line Treatment for Contact Dermatitis
For both irritant and allergic contact dermatitis, the first-line treatment is identification and complete avoidance of the causative agent, combined with mid-to-high potency topical corticosteroids for inflammation and aggressive emollient therapy to restore the skin barrier. 1
Distinguishing Between Irritant and Allergic Contact Dermatitis
- Clinical features alone are unreliable in distinguishing between irritant and allergic contact dermatitis, particularly on hands and face, making patch testing essential when the diagnosis remains uncertain. 2, 1
- Irritant contact dermatitis results from direct chemical damage without immune involvement, typically from repetitive exposure to soaps, detergents, solvents, or single overwhelming exposures to caustic agents. 2, 3
- Allergic contact dermatitis involves delayed-type hypersensitivity (Type IV) to specific allergens like nickel, fragrances, preservatives, or rubber chemicals, requiring prior sensitization. 2
- Allergic contact dermatitis carries a worse prognosis than irritant dermatitis unless the specific allergen is identified through patch testing and completely avoided. 3
First-Line Treatment Protocol
Immediate Management for Both Types
- Apply mid-to-high potency topical corticosteroids such as triamcinolone 0.1% or betamethasone valerate 0.1% to affected areas 3-4 times daily for localized disease. 1, 4, 5
- For severe or recalcitrant cases, escalate to very high potency topical corticosteroids like clobetasol propionate 0.05% for up to 2 weeks, which achieves clear or almost clear skin in 67.2% of patients with severe dermatitis. 1, 5
- Replace all soaps and detergents with emollients immediately, as these are common irritants that perpetuate dermatitis. 1
- Apply moisturizers liberally using the "soak and smear" technique: soak affected areas in plain water for 20 minutes, then immediately apply two fingertip units of moisturizer to damp skin. 1
- Use moisturizers packaged in tubes rather than jars to prevent contamination. 1
Allergen Identification and Avoidance
- Refer for patch testing with at least an extended standard series of allergens if dermatitis persists beyond 2-3 weeks, if the pattern is atypical, or if the causative agent remains unknown. 2, 1
- Patch testing has 70-80% sensitivity and specificity for confirming allergic contact dermatitis and identifying specific allergens. 3
- Take a detailed history including initial symptom location, spread pattern, relationship to specific products or activities, and occupational/recreational exposures. 1
- Consider workplace visits if occupational exposure is suspected to identify hidden allergens and assess procedures causing accidental exposure. 1
Protective Measures
- Use appropriate protective gloves based on suspected exposures: rubber or PVC gloves with cotton liners for household tasks, neoprene or nitrile for latex allergy. 1
- Remove gloves regularly to prevent sweat accumulation, which aggravates dermatitis. 1
- Apply moisturizer before wearing gloves to enhance barrier protection. 1
- Do not over-rely on barrier creams alone, as they have questionable value and may create false security. 1
Systemic Therapy for Extensive Disease
- If allergic contact dermatitis involves greater than 20% body surface area, oral prednisone is required and provides relief within 12-24 hours. 6, 5
- For severe rhus (poison ivy) dermatitis, taper oral prednisone over 2-3 weeks to prevent rebound dermatitis from rapid discontinuation. 5
- Avoid oral corticosteroids during patch testing; if unavoidable, keep prednisolone ≤10 mg daily to prevent false-negative results. 1
Second-Line Therapies for Refractory Cases
- Consider topical tacrolimus 0.1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage. 2, 1
- PUVA phototherapy is an established second-line treatment for chronic hand eczema resistant to topical steroids. 2, 1
- For severe chronic hand eczema, alitretinoin is recommended by the British Association of Dermatologists. 2
- Systemic immunosuppressants like azathioprine or ciclosporin may be considered for steroid-resistant chronic cases. 1
Critical Pitfalls to Avoid
- Never wash hands with dish detergent or other known irritants, use very hot or very cold water, or apply disinfectant wipes to clean hands. 1
- Avoid prolonged occlusion without underlying moisturizer application, as this worsens barrier dysfunction. 1
- Exercise extreme caution with topical corticosteroids on facial skin—prolonged use causes skin thinning, telangiectasia, perioral dermatitis, and red face syndrome due to increased percutaneous absorption. 1
- Do not apply potent topical steroids to the back within 2 days of patch testing, as this causes false negatives. 1
- Avoid products containing topical antibiotics without indication, as these are common sensitizers, particularly in children. 1, 3
- Be aware that a small subset of patients may develop allergic contact dermatitis to topical corticosteroids themselves, requiring patch testing to corticosteroid allergens. 2, 7
Prognosis Considerations
- Only 25% of patients with persistent contact dermatitis achieve complete healing over 10 years, with 50% having intermittent symptoms and 25% having permanent symptoms despite treatment. 1
- Early identification and complete avoidance of allergens offers the best chance for resolution. 1
- Changing occupation does not improve prognosis in 40% of cases of occupational contact dermatitis. 1